دورية أكاديمية

Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.

التفاصيل البيبلوغرافية
العنوان: Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
المؤلفون: Schwartz, Jonathan D., Barcellini, Wilma, Grace, Rachel F., Bianchi, Paola, Zanella, Alberto, López Lorenzo, José Luis, Sevilla, Julián, Shah, Ami J., Glader, Bertil, Nicoletti, Eileen, Navarro Ordoñez, Susana, Segovia, José Carlos
المصدر: American Journal of Hematology; Mar2022, Vol. 97 Issue 3, pE120-E125, 6p
قاعدة البيانات: Complementary Index
الوصف
تدمد:03618609
DOI:10.1002/ajh.26458